It is a single-dose, controlled research exposure in a small sample, which cannot predict the effects of repeated, unsupervised cannabis use.What risks does this study not address?It does not address mood destabilization, mania or hypomania risk, psychosis risk, sleep, medication interactions, or cannabis use disorder, all established concerns in bipolar disorder.Should patients change their cannabis use based on this study?No
If you choose to eat peanut butter during tirzepatide treatment, smaller portions work best
*Este producto es de uso exclusivo profesional.
These drug manufacturers didnt share these findings with doctors so that they could adjust their patients dosage, which would have potentially reduced their risk for this condition
No, they complement a healthy lifestyle and work best when combined with a balanced diet and exercise
Study 7 was a 64-week trial that enrolled 307 patients with obesity (BMI greater than or equal to 30 kg/m2) or with overweight (BMI 27-29.9 kg/m2) and at least one weight-related comorbid condition, such as treated or untreated dyslipidemia or hypertension